Side-by-side comparison of AI visibility scores, market position, and capabilities
Berlin YC W21 telecom-as-a-service enabling any brand to launch MVNO in days; $97.1M total ($73M Ribbit/Google Series B Dec 2024) serving Nubank, Wealthsimple with embedded mobile competing with Bandwidth for MVNO infrastructure.
Gigs is a Berlin, Germany-based telecom-as-a-service platform — backed by Y Combinator (W21) with $97.1 million in total funding including a $73 million Series B in December 2024 led by Ribbit Capital with Google's Gradient Ventures, Y Combinator, and Speedinvest — providing technology companies with MVNO-as-a-service infrastructure that enables any brand to launch its own wireless mobile service in days without building carrier relationships, spectrum licenses, or telecom infrastructure. Serving leading tech brands including Nubank, Wealthsimple, HR platforms, travel companies, and phone manufacturers, Gigs enables embedded connectivity as a feature — allowing businesses to offer mobile plans to their customers as a native product extension that increases retention and creates new revenue streams.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.